Assessment Outcomes Effect Covid 19 on Pregnancy

Abstract

Introduction: Pregnant patients become susceptible when their cell-mediated immunity is compromised. During pregnancy, anatomical and physiological alterations such as diaphragm ascension, changes in lung capacity, vasodilation, mucosal edema, and anemia all contribute to susceptibility to hypoxia. Objective: This paper aims to assess outcomes that affect COVID-19 on pregnancy. Patients and Methods: Data were collected retrospectively through reviews of electronic medical records or electronic hospital records and discharge data for all pregnancy patients in different hospitals in Iraq between 4^th July 2021 to 9^th January 2022 who were >30 years of age or older. These data were designed with two groups. Where the first group was represented with pregnancy patients, explain the women patients have Covid-19 and struggled during the period of Covid-19, while the second group was represented the control group that, which explains the pregnancy group who have Covid-19 and could treated of it. A statistical study was conducted for pregnancy patients using the SPSS program. Results and Discussions: Effects of SARS infection on mothers and their babies. Research shows pregnant women infected with COVID-19 are more likely to develop serious illnesses, including a higher risk of preterm labor and maternal and/or fetal mortality. As a result, this study showed that the BMI in the group of pregnant patients was higher than that of the control group, and the group of pregnant patients was (31 ± 2.1) while the control group was (30 ± 1.9) with a P-value of 0.0492, while the Parity group of pregnant patients was (2.70 ± 1.34) and the control group (1.67 ± 1.13). As for smoking, most of the patients for both groups did not smoke, which included in the pregnant group, 56 (93.33%), while the control group, 57 (95%), with a P-value of 0.0485. In terms of obstetric problems, we saw an increase in the incidence of caesarean delivery and fetal hypoxia corrected after birth but a decrease in the rate of other disorders mentioned in the literature, such as preeclampsia where Preterm birth <37 weeks got 7 (11.67%) in the pregnancy patients, but 5 (8.33%) for the controls patients. As well as, Iatrogenic (<37 weeks) shown high with 6 (10%) in the pregnancy patients and 3 (5%) in the control patients with a p-value of 0.0344. Conclusion: Yet the effects of COVID-19 on fetal development appear to be considerable, and maternal outcomes for women with COVID-19, as well as for asymptomatic women where COVID-19 has a large influence, making this inconsistent Reassuring for expecting moms and those who care for them. Perinatal mortality has increased in the world because of this epidemic, according to research.